IMMUNOVATION

Serial Number 97448256
Registration 7430005
700

Registration Progress

Application Filed
Jun 8, 2022
Under Examination
Mar 5, 2024
Approved for Publication
Jan 9, 2024
Published for Opposition
Jan 9, 2024
Registered
Jun 25, 2024

Trademark Image

IMMUNOVATION

Basic Information

Serial Number
97448256
Registration Number
7430005
Filing Date
June 8, 2022
Registration Date
June 25, 2024
Published for Opposition
January 9, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 25, 2024
Registration
Registered
Classes
035 041 042 044

Rights Holder

ImmunoVation, LLC

16
Address
7100 Cerritos Ave Unit 81
Stanton, CA 90680

Ownership History

ImmunoVation, LLC

Original Applicant
16
Stanton, CA

ImmunoVation, LLC

Owner at Publication
16
Stanton, CA

ImmunoVation, LLC

Original Registrant
16
Stanton, CA

Legal Representation

Attorney
Gunnar Bjorn Gundersen

USPTO Deadlines

Next Deadline
1646 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240625)
Due Date
June 25, 2030
Grace Period Ends
December 25, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

29 events
Date Code Type Description Documents
Sep 9, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 9, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 9, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 25, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 25, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 20, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 20, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 16, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 27, 2024 IUAF S USE AMENDMENT FILED Loading...
Apr 16, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 27, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 5, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 9, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 9, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 20, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 6, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 29, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Nov 29, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Nov 29, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Nov 27, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 27, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 27, 2023 ALIE A ASSIGNED TO LIE Loading...
Jun 21, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 23, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 23, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 23, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 23, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 22, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 11, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Promoting public awareness of immunological issues, drug development, and women's health; promoting the interests of women by means of public advocacy
First Use Anywhere: Aug 9, 2019
First Use in Commerce: Aug 9, 2019
Class 041
Educational services, namely, providing pre-recorded performances in the nature of non-downloadable audio and video clips in the field of immunological issues, drug development, and women's health; Providing a web site featuring pre-recorded performances in the nature of non-downloadable audio and video clips in the field of immunological issues, drug development, and women's health
First Use Anywhere: May 23, 2022
First Use in Commerce: May 23, 2022
Class 042
Providing scientific research information in the field of immunological issues, drug development, and women's health; providing a website featuring scientific research information in the field of immunological issues, drug development, and women's health
First Use Anywhere: Aug 9, 2019
First Use in Commerce: Aug 9, 2019
Class 044
Pharmaceutical consulting services in the fields of immunology, drug development, and women's health; Providing a website featuring medical and pharmaceutical information on immunology, drug development, and women's health; Providing medical and pharmaceutical information about immunology, drug development, and women's health; Health counseling services in the field of services in the field of immunology, drug development, and health and wellness for women
First Use Anywhere: Aug 9, 2019
First Use in Commerce: Aug 9, 2019

Classification

International Classes
035 041 042 044